SHLEVIN HAROLD H. (Chief Executive Officer) sold 79.0% of their position (24.50K shares) of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $172.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/19/2025ACC: 0001133416-25-000067
Officer· Chief Executive Officer
Since Jan 2019
-24.50K
Net shares
Net seller
$172.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
20K acquired · 44.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20K
Price / share
$1.98
Trade value
$39.60K
% of position
178.5%
12/17/2025
11.21K→31.21K
Common Stock
Direct
Shares
−19.79K
Price / share
$7.04
Trade value
$139.30K
% of position
63.9%
12/17/2025
31K→11.21K
Common Stock
Direct
Shares
−4.71K
Price / share
$7.04
Trade value
$33.12K
% of position
42.0%
12/17/2025
11.21K→6.50K
Total
Net shares
−4.50K
Net value
-$132.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2025 | M · Option Exercise | +20K | $1.98 | $39.60K | 178.5% | 11.21K | 31.21K |
| Common Stock Direct | 12/17/2025 | S · Sale | −19.79K | $7.04 | $139.30K | 63.9% | 31K | 11.21K |
| Common Stock Direct | 12/17/2025 | S · Sale | −4.71K | $7.04 | $33.12K | 42.0% | 11.21K | 6.50K |
| Total | −4.50K | -$132.82K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
1.98
Held after
0.00
Exercisable
—
12/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 12/17/2025 | M · Option Exercise | −20K | 1.98 | — | 0.00 |